Calcitriol may decrease prostate specific antigen (PSA) levels in men with castration resistant PCa [46] and may decrease the rate of rise of PSA in men with early recurrent PCa [19], but dose-limiting hypercalcemia and hypercalciuria develops in patients when daily calcitriol is administered. This evidence concerns the gene KLK3 and hypercalcemia disease.